Brazilian Pharmaceutical Market

  • Uploaded by: Marcelo Sicoli
  • 0
  • 0
  • May 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Brazilian Pharmaceutical Market as PDF for free.

More details

  • Words: 6,637
  • Pages: 2
Pharmaceutical Commerce

1 de 2

http://www.pharmaceuticalcommerce.com/frontEnd/1091-Brazil_ANVI...

Home

Contact Us

SUBSCRIBE

RESOURCES

Search Registered user? Log-In here E-mail:

EDITORIAL Opinion Business and finance Supply Chain/Logistics Information Technology Packaging/Drug Delivery Marketing/Services Legal/Regulatory Executive Training & Development LATEST NEWS MEDIA INFORMATION: 2009 MEDIA KIT SUBSCRIBE

Password: Remember me on this computer?

Log In Forgot your password? New user?

Executive Training & Development Entering the Brazilian Pharmaceutical Market By: Marcelo Sicoli, EnterBrazil

Date: 2009-02-22

Register here

CURRENT ISSUE

S t a bl e e c o n o m i c s a n d g r o w i n g he a l t h c a r e c o n c e r n s m a k e B r a z i l o ne o f t h e t o p e m e r g i n g m a r k e t s , w i t h a c u r r e n t g r o w t h r a t e > 20 %

RESOURCES Search

M a n y a n a l y s t s a r g ue t h a t t h e f u t u r e f or B r a z i l , w hi c h ha s b e e n c a l l e d f or de c a d e s “ t h e c o u n t r y o f t h e fu t u r e , ” ha s f i n a l l y a r r i v e d . W i t h i nf l a t i o n u n de r c o nt ro l a nd e c o no mic gro w t h a bo ve t he w o rld a v e r a g e ( 5 .4 % a n d 5. 3 % i n 2 0 0 7 a n d 2 0 0 8, r e s p e c t i v e l y ) i t s c o ns i d e r a b l e p o pu l a t i on o f a l m os t 2 00 m i l l i o n p r e s e nt s v e r y a t t r a c t i v e p r o s p e c t s f o r p ha r m a c e u t i c a l c o m p a ni e s a l l o v e r t h e w o r l d . T h e h e a l t h s e c t or a s a w h o l e r e p r e s e nt s 8 % o f t he B r a z i l i a n GD P, a r o u nd U S$ 8 0 bi l l i on p e r y e a r . G ov e r nm e n t p u r c h a s e s r e p r e s e n t 50 % of t h e m a r k e t f or m e di c a l e qu i p m e n t s , a nd m o r e t h a n 9 0 % o f t h e va c c i nes a nd 2 5 % o f a ll drugs ( B ra z il ia n M inis t ry o f Hea lt h). I n 2 00 8 , t he B r a z i l i a n p ha r m a c e u t i c a l m a r k e t w a s e s t i m a t e d t o r e a c h U S $ 1 4 . 9 b i l l i o n , 3 4 % o f L a t i n A m e r i c a , j um pi n g 2 3 % f r o m 2 00 7 ( I M S H e a l t h ) . T w e n t y p e r c e n t of t h a t i s m a d e up o f g e ne r i c d r u gs , w h i c h c o s t o n a v e r a ge 3 5% l e s s t ha n r e f e r e n c e d r u gs ( P r o g e ne r i c o s ) . B r a z i l i a n c om p a n i e s h a v e a m a r k e t s h a r e o f a r o u nd 2 0 % o n l y .

Workforce and Supply Chain Top Location Must-Have Lists for Biopharma

O n t h e f o r e i g n t r a de s i de , B r a z i l i a n pr od u c t s t o t a l e d m o r e t h a n U S $ 96 1 m i l l i o n i n e x p or t s i n 2 00 8 , a 2 9 % i n c r e a s e f r o m 2 00 7 . T he m a i n e x p or t m a r k e t s a r e V e n e z u e l a ( 14 % ) , A r g e nt i n a ( 1 3 % ) a nd t h e U S A ( 1 2 % ) . O n t h e o t h e r h a n d , i m p o r t s a m o u n t e d t o U S $ 4. 2 8 bi l l i on , a n i n c r e a s e o f 2 1 % y e a r o v e r y e a r , c o m i n g m a i n l y f r o m t h e U S A ( 19 % ) , G e r m a n y a n d S w i t z e r l a n d ( 1 3 % e a c h ) . F o r e x a m p l e , a l l 4 5 0 t o ns o f a m ox i c i l l i n ( a nt i b i o t i c s ) c o ns um e d p e r y e a r a r e i m p o r t e d .

Despite historic risk during the metamorphosis from glamorous high-tech startup to pillar-of-thecommunity manufacturer-employer, biopharmaceutical companies remain near the top of the list of industries that US states see as key to their economic future. Biotechs looking for a place to throw down roots . . .

E s t i m a t e s p oi n t ou t t ha t 3 0 % o f t h e d r u g s s o l d i n B r a z i l a r e n o t r e gi s t e r e d . A c c o r d i n g t o t he B r a z i l i a n F e d e r a l P ol i c e , 50 0 t h o us a n d un i t s ( 13 0 t o ns ) o f n on - r e g i s t e r e d a n d c ou n t e r f e i t m e d i c a t i o ns w e r e s e i z e d i n 20 0 8 , m a i nl y a m ph e t a m i ne s , s t e r oi ds , c on t r a c e p t i v e s a nd d r u gs fo r e r e c t i l e dy s f u nc t i o n . N e w l e g i s l a t i o n ( t o b e i m pl e m e n t e d g r a du a l l y du r i ng t h e ne x t t hr e e y e a r s ) w a s pa s s e d i n J a n u a r y o f 2 0 0 9 b y t h e Se n a t e t o e n f or c e m on i t o r i n g o f m e d i c a l p r o d uc t s v i a e l e c t r o n i c b a r c o d e s y s t e m s o n t h e p r o d u c t i on , c o m m e r c i a l i z a t i on , d i s t r i b u t i o n , a n d m e di c a l p r e s c r i p t i o n of d r u gs .

SPECIAL FOCUS REPORT

Fed eral reg ulato ry b od ies T h e N a t i o n a l H e a l t h S u r v e i l l a nc e A g e nc y ( A N V I S A ) , c r e a t e d i n 1 99 9 , i s t h e e q u i v a l e n t o f t h e A m e r i c a n F D A . A NV I S A i s a n i n d e pe n d e n t l y m a na g e d, f i n a nc i a l l y - a ut o no m o u s r e g ul a t or y a ge n c y , w i t h s e c u r i t y o f t e n u r e fo r i t s d i r e c t or s du r i n g t h e p e r i o d o f t h e i r m a nd a t e s . A NV I S A i s m a na g e d b y a bo a r d of d i r e c t or s , c o m p r i s e d o f f i v e m e m b e r s . Wi t h i n t h e s t r u c t u r e o f F e d e r a l Pu b l i c A d m i ni s t r a t i o n, t h e A g e n c y i s l i n k e d t o t h e M i n i s t r y o f H e a l t h , u n d e r a M a n a g e m e n t C on t r a c t . T h e a g e nc y i n c o r p o r a t e s a dd i t i o na l m a n d a t e s : c o o r d i n a t i o n of t h e Na t i on a l S a n i t a r y S ur v e i l l a n c e S y s t e m ( S NV S ) , t h e N a t i on a l P r o g r a m of B l o o d a n d B l o o d P r o d u c t s a n d t h e N a t i o n a l P r o gr a m o f P r e v e nt i o n a n d C on t r o l of H os pi t a l I n f e c t i o n s ; m on i t or i n g o f d r u g p r i c e s a n d pr i c e s o f m e d i c a l de v i c e s ; a t t r i b u t i o n s p e r t a i n i n g t o r e g u l a t i o n , c o n t r o l a n d i n s p e c t i o n o f s m o k i n g pr od u c t s ; t e c h n i c a l s u p p or t i n gr a n t i n g o f p a t e n t s b y t h e N a t i o n a l I n s t i t u t e o f I n d us t r i a l P r o p e r t y . A N V I S A i s h e a d q ua r t e r e d i n t h e c a p i t a l o f B r a z i l , B r a s i l i a , p r e s e n t l y t he f ou r t h - l a r g e s t c i t y i n t h e c ou n t r y . I n a d d i t i o n, A NV I S A e x e r c i s e s c o n t r o l o v e r p o r t s , a i r p o r t s a n d bo r d e r s a n d a l s o l i a i s e s w i t h t he B r a z i l i a n M i n i s t r y o f F o r e i g n A f f a i r s a n d f o r e i g n i n s t i t ut i o n s ov e r m a t t e r s c on c e r ni ng i n t e r n a t i o n a l a s p e c t s o f s a n i t a r y s u r v e i l l a n c e . M o r e i n fo r m a t i o n , a s w e l l a s m a n y r e l e v a n t l a w s i n E n g l i s h c a n be o bt a i n e d f r o m t h e a g e nc y ’ s w e bs i t e . [ 1] U S P h a r m a c o pe i a r e c o g n i z e d t h e v a l u e of t h e B r a z i l i a n m a r k e t b y op e n i n g i t s f o ur t h o v e r s e a s l o c a t i o n ( a f t e r S w i t z e r l a nd , I n d i a a n d C hi n a ) i n S a o P a u l o l a s t A u g us t . “ B r a z i l ha s o n e o f t h e f a s t e s t - g r o w i ng p h a r m a c e ut i c a l i n d u s t r i e s i n t h e w o r l d , [ a n d ] i s i n c r e a s i n gl y a dh e r i n g t o i n t e r n a t i o n a l q u a l i t y s t a n d a r ds ,” s a i d D r F l a v i o V o r m i t t a g , M D , M S , V P, i n t e r n a t i on a l , fo r U S P . K e y t r a d e a s s o c i a t i o n s i n c l ud e F e b r a f a r m a , t h e B r a z i l i a n P ha r m a c e u t i c a l I n d u s t r y

22/6/2009 18:23

Pharmaceutical Commerce

2 de 2

http://www.pharmaceuticalcommerce.com/frontEnd/1091-Brazil_ANVI...

F e d e r a t i o n , I n t e r f a r m a , t he B r a z i l i a n R e s e a r c he d - b a s e d P h a r m a c e u t i c a l M a n u f a c t u r e r s A s s n . , a n d Pr oG e n e r i c o s , t h e B r a z i l i a n A s s n. o f G e n e r i c D r u g s I n d us t r y ( s e e bo x ) . I n t e r f a r m a i s t h e r e p r e s e nt a t i v e o r g a n i z a t i o n t o t he U .S . ’ s P ha r m a c e u t i c a l R e s e a r c h a n d M a n uf a c t u r e r s A s s n . ( P hR M A ) . I n t e l le c t u a l p ro p e r t y ri g h t s I n B r a z i l , n o he a l t h- r e l a t e d p r o d u c t c a n be p r o du c e d , i m p o r t e d , e x p o s e d f o r s a l e , o r d e l i v e r e d fo r c o n s u m p t i on b e f o r e a r e g i s t r a t i on i s o b t a i n e d f r o m A N V I S A . B e f o r e t h a t , a c o m p a n y ha s t o b e f i r s t r e g i s t e r e d w i t h t h e s t a t e l e v e l h e a l t h a u t h o r i t y a n d t h e n i n t h e F e d e r a l l e v e l ( d on e by A N V I S A ) . I f a c o m p a ny d o e s no t w a n t t o s t a r t f or m a l op e r a t i on s i n t h e B r a z i l i a n t e r r i t or y a nd o nl y e x p or t pr o du c t s t o t h e c o u n t r y , t h e r e i s t h e p o s s i b i l i t y o f h i r i n g a c o m p a n y o r f i n d i n g a d i s t r i b u t o r a l r e a dy l e ga l i z e d t o be c o m e a n e x c l u s i v e d i s t r i b u t o r o f t he f or e i g n p r o d uc t s i n B r a z i l . T h e r e g i s t r a t i on o f a d r u g i s v a l i d f or 5 y e a r s , a nd t h e c o s t s v a r y a c c o r d i n g t o t he s i z e o f t h e c o m p a n y r e q ue s t i n g i t . A l a r g e c o m p a n y ( r e v e n u e a b ov e U S $2 5 m i l l i o n ) f or e x a m p l e , w ou l d s p e nd R $ 8, 0 0 0 ( U S$ 4 , 0 00 ) fo r l i c e n s i n g a n e w p r o d uc t , w h i l e t he r e g i s t r a t i o n o f a “ f a m i l y ” o f pr od u c t s ( s a m e d r u g w i t h d i ff e r e n t s i z e s a n d p r e s e nt a t i o n s ) w o u l d c os t R $ 1 2 ,0 0 0 ( U S $ 6, 0 0 0) . J us t t o r e c e i v e a v i s i t fr om a n A NV I S A t e c h n i c i a n t o o bt a i n a “ C e r t i fi c a t e of G oo d M a n u f a c t u r i n g Pr a c t i c e s ,” a c o m p a ny w i l l h a v e t o s p e n d U S $1 8 , 50 0 , r e ga r d l e s s of i t s s i z e . O n e p o i n t o f c on c e r n f o r fo r e i gn c o m p a ni e s i s t h e o b s e r v a n c e o f i nt e l l e c t u a l p r o p e r t y r i g h t s . A t l e a s t i n c o m p a r i s on w i t h R u s s i a , I nd i a a n d C h i n a , B r a z i l i s b e s t p os i t i on e d i n r e ga r d s t o t h e T R I P S ( A g r e e m e n t o n T r a d e - R e l a t e d A s p e c t s o f I nt e l l e c t u a l P r o pe r t y R i g ht s ) n o r m s . N o n e t he l e s s , i n e m e r g e nc y s i t ua t i o ns , n a t i o n a l l e g i s l a t i o n a llow s the c ance ll at ion of pat ents ( or “ compuls ory l ice ns ing” a s it is ca ll ed) , a s s e e n i n M a y 2 0 07 , w i t h t h e a n t i - A I D S dr ug E f a v i r e n z , p r o du c e d b y M e r c k S ha r p & D oh m e , e v e n a f t e r a n o f fe r w a s m a d e b y t h e c o m p a n y t o l o w e r t h e p r i c e b y 3 0 % . A m a j o r c r i t i c i s m o f t h e l e g i s l a t i o n ( w h i c h p r o v i d e s t h a t t h e A g e nc y h a s 9 0 da y s t o a s s e s s t h e p r o c e s s e s f i l e d w i t h i t ) i s t h a t i t d o e s n ot m e n t i on a de a d l i n e fo r t h e e v a l u a t i o n o f t e c h ni c a l r e q ui r e m e n t s , w h i c h c a u s e s s o m e p e t i t i on s t o t a k e m o r e t h a n a y e a r t o b e f i n a l i z e d, s i nc e t h e y e n t e r a w a i t i ng l i s t w i t h n o r e g u l a t i o n . D o i n g b u s in e s s in B r a z i l M a n y p o s i t i v e a s pe c t s o f t h e B r a z i l i a n ph a r m a c e u t i c a l m a r k e t d r a w t he a t t e n t i o n of f or e i gn e r s . M o s t s e n i o r o ff i c i a l s i n t h e M i n i s t r i e s a nd R e g u l a t o r y A g e nc i e s d o n o t s p e a k E ng l i s h . H o w e v e r , s om e j u ni or of f i c i a l s c a n b e f ou n d w i t h g o o d k n o w l e dg e o f t h e l a n g u a g e . A l t h ou g h t h e c o u n t r y i s s t i l l p l a c e d i n i nt e r m e di a r y p os i t i o n s o f w o r l d c o r r u p t i o n r a n k i n g s , t h e f a c t t h a t t h e B r a z i l i a n F e d e r a l Go v e r n m e n t p a y s e m p l o y e e s s a l a r i e s s om e t i m e s 3 t o 4 t i m e s hi gh e r t h a n t ho s e f ou n d i n t he p r i v a t e s e c t o r on a n e nt r y l e v e l a c t s a s a n i m p o r t a n t d i s i nc e n t i v e . W i t h q u a l i f i e d p r of e s s i on a l s f r o m t o p u ni v e r s i t i e s c o m p e t i n g fo r a p ub l i c j ob , pr i v a t e c o m p a ni e s i n s om e i n d u s t r i e s h a v e a h a r d t i m e t o f i n d q ua l i fi e d p r o f e s s i o n a l s . B r a z i l i a n s , c u l t u r a l l y s p e a k i n g, a r e a l w a y s v e r y o pe n a n d r e c e p t i v e t o f or e i g ne r s i n i n f or m a l s o c i a l e n v i r on m e n t s a s w e l l a s i n t h e c o r po r a t e r e a l m . O n e t hi n g t o b e h i g hl i g ht e d, h ow e v e r , i s t h a t c o m p a n i e s ne e d t o e s t a b l i s h a p u bl i c p e r c e p t i o n of g e n e r a t i n g j ob s a n d p r o m o t i ng p ub l i c h e a l t h, a n d n o t o f p u t t i ng p r o fi t a b i l i t y f i r s t . O n e o f t h e m o s t c o m p l e x a n d h i g he s t t a x bu r d e n i n t he w or l d a l s o p o s e s s e r i ou s c h a l l e n ge s f o r c o m p a ni e s op e r a t i n g o r pl a n n i n g t o s t a r t a c t i v i t i e s i n t h e B r a z i l i a n t e r r i t o r y . A c c o r d i n g t o a r e p o r t b y t h e W o r l d B a n k , a c o m p a n y c a n s pe n d u p t o 72 % o f i t s p r o fi t s o n t a x e s a n d t a k e 2 , 6 0 0 h o ur s pe r y e a r t o f u l f i l l b u r e a u c r a t i c o bl i g a t i o n s , c om pa r e d t o 43 0 . 5 h o u r s i n ot h e r L a t i n A m e r i c a n C ou n t r i e s a n d 2 02 . 9 i n t he de ve lo pe d w o rld. PC

A B O U T TH E A U TH OR M a r c e l o S i c o l i i s e x e c u t i v e m a n a ge r o f E n t e r B r a z i l C on s u l t a nc y ( e n t e r b r a z i l . c o m , t e l : 5 5 ( 6 1 ) 3 3 6 1 1 8 6 9, e - m a i l , m a r c e l o s i c o l i @ ho t m a i l . c o m ) , i n B ra s il ia . E nt er Bra z il s pec ia liz es i n ma r ke t s t udie s , d i r e c t c o n t a c t w i t h i m p o r t e r s / e x po r t e r s , a n d t h e c om pl e t e i m p l e m e nt a t i o n p r o c e s s o f o pe n i n g a n d m a n a g i n g a b us i n e s s o ff i c e i n t h e B r a z i l i a n t e r r i t or y . R e c e n t c l i e nt s i n c l u d e S c h e r i ng - P l o u g h ( U S A ) , T a t e & L y l e ( E ng l a n d ) , F e de x ( U SA ) , Se r u m I ns t i t ut e - V a c c i ne s ( I n d i a ) .

Home Pharmaceutical Commerce © 2009

Contact Us

SUBSCRIBE

RESOURCES

Search

RSS Developed by

22/6/2009 18:23

Related Documents


More Documents from "bertrand t"

June 2020 15
Beer Stories
May 2020 17
Charlacelulas27
August 2019 20
June 2020 15